Detecting Risk and Predicting Patient Mortality in Patients with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections

EM Trecarichi, R Cauda, M Tumbarello - Future microbiology, 2012 - Taylor & Francis
β-lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum
β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. …

Clinical risk score for prediction of extended-spectrum β-lactamase–producing Enterobacteriaceae in bloodstream isolates

MR Augustine, TL Testerman, JA Justo… - infection control & …, 2017 - cambridge.org
… to predict probability of bloodstream infections (BSIs) due to extended-spectrum β-lactamase–…
Point allocation in extended-spectrum β-lactamase prediction score (ESBL-PS) was based …

Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis

I Fröding, JK Valik, L Bolinder, P Nauclér… - International journal of …, 2019 - Elsevier
… The strongest predictor of EPE-BSI was prior EPE-positive … Prediction in patients lacking
major predictors was difficult … in 8% of Escherichia coli from bloodstream infections (BSIs) in …

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score

BJ Haimerl, R Encinas, JA Justo, J Kohn… - Antibiotics, 2023 - mdpi.com
… Clinical tools for the prediction of antimicrobial resistance have … -lactamase (ESBL) prediction
score on the time to initiation of appropriate antimicrobial therapy for bloodstream infection (…

Clinical prediction tool for extended‐spectrum betalactamase‐producing Enterobacterales as the etiology of a bloodstream infection in solid organ transplant …

R Wang, JH Han, E Lautenbach… - Transplant Infectious …, 2021 - Wiley Online Library
… -EB infections among SOT recipients. Thus, in this study, we developed a clinical prediction
tool to determine the risk for ESBL-EB as the etiology of EB BSI at the time of blood culture …

Clinical prediction score for community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species

M Kim, KH Song, CJ Kim, PG Choe… - Journal of Korean …, 2019 - synapse.koreamed.org
… build a prediction score for community-onset bloodstream infections (CO-BSIs) caused by
extended-spectrum betalactamase (… A prediction score was built using the coefficients of the …

A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase–producing organism

KE Goodman, J Lessler, SE Cosgrove… - Clinical Infectious …, 2016 - academic.oup.com
… Our objective was to develop a user-friendly decision tree to predict, at the time of organism
identification from a blood culture, which bacteremias are due to ESBL producers in order to …

Deep learning model for prediction of extended-spectrum beta-lactamase (ESBL) production in community-onset Enterobacteriaceae bacteraemia from a high ESBL …

ALH Lee, CCK To, ALS Lee, RCK Chan… - … & Infectious Diseases, 2021 - Springer
… -onset sepsis and bloodstream infection include beta-lactam beta-lactamase inhibitors (…
bloodstream infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase (…

Predicting resistance to piperacillin-tazobactam, cefepime and meropenem in septic patients with bloodstream infection due to gram-negative bacteria

MC Vazquez-Guillamet, R Vazquez… - Clinical Infectious …, 2017 - academic.oup.com
Predicting antimicrobial resistance in gram-negative bacteria (GNB) could balance the need
… to develop a practical prediction rule able to identify patients with GNB infection at low risk …

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase …

…, B Gutiérrez-Gutiérrez… - Journal of …, 2017 - academic.oup.com
… In this analysis, because the prediction rule was to be used on day 3, only early targeted
drugs (ie those administered on that day, which is the day when susceptibility results are …